ACO Name and Location
JFK Population Health Company, LLC dba. JFK Health ACO
Previous Names: N/A
98 James Street Suite 304
Edison, NJ 08820
ACO Primary Contact
Primary Contact Name | Sheilah McCoy BSN, RN |
Primary Contact Phone Number | 732-744-5980 |
Primary Contact Email Address | sheilah.mccoy@hmhn.org |
Organizational Information
ACO Participants |
ACO Participant in Joint Venture (Enter Y or N) |
Allison L Faches PA |
N |
Bruce Soriano |
N |
Brunswick Internal Medicine Group, PC |
N |
Cardiovascular Consultants, PA |
N |
CGF Medical Center PA |
N |
Clarabarton Cardio Medical Association Inc. |
N |
Coastal Medical Group, PA |
N |
Community Hospital Group Inc |
N |
Dewan S. Khan M.D., P.C. |
N |
Edison Nephrology Consultants |
N |
Endocrinology T&S |
N |
Fauzia Hameed, MD, LLC |
N |
Forrayan LLC |
N |
Harry Collins, MD LLC |
N |
Healthy Life MD, LLC |
N |
Indravadan T Patel MD PA |
N |
Janardhan Bollu |
N |
Janardhan Bollu MD PA |
N |
Jasbir K.Kasuri MD PC |
N |
Jersey Heart Center LLC |
N |
JFK Medical Associates, PA |
N |
JFK Medical Group, PC |
N |
Joseph Robbins |
N |
Kespra Medical Center LLC |
N |
Ketankumar Vaidya, LLC |
N |
Kishore Ramchandani |
N |
Linden Medical Group, LLC |
N |
M.A. Sarraf, M.D., P.A. |
N |
Menlo Park Medical Group P.A. |
N |
Mid Jersey Medical Associates PA |
N |
Mohammad A. Zubair, LLC |
N |
Nandini Moray, MD PA |
N |
Neha Shah MD LLC |
N |
Oak Tree Family Practice, LLC |
N |
Oak Tree Patient Care PC |
N |
Pradip A. Shah, M.D. P.C. |
N |
Primary Care Nj Llc |
N |
Pulmonary Internists, PA |
N |
Richard Menashe |
N |
Shefali Patel |
N |
Sunil Patel |
N |
Syed Siddiq |
N |
Thomas J. Cassidy MD LLC |
N |
ACO governing body:
Member |
Member's Voting Power – Expressed as a percentage or number |
Membership Type |
ACO Participant Legal Business Name/DBA, if Applicable |
||
Last Name |
First Name |
Title/Position |
|||
Sharma |
Bhudev |
Chair |
1 |
ACO Participant Representative |
JFK Medical Associates |
Flores |
Maria |
MD |
1 |
ACO Participant Representative |
JFK Medical Associates |
Patel |
Rajesh |
DO |
1 |
ACO Participant Representative |
Forrayan |
Vaidya |
Ketankumar |
MD |
1 |
ACO Participant Representative |
Ketan Vaidya, MD, LLC |
Oser |
William |
ACO Executive Director |
0 |
Other |
|
Rossy |
William |
MD |
1 |
ACO Participant Representative |
JFK Medical Associates |
Soriano |
Bruce |
MD |
1 |
ACO Participant Representative |
Bruce V. Soriano, MD |
Spirn |
Franklin |
MD |
0 |
Medicare Beneficiary Representative |
|
Thornton |
Amie |
CHE |
1 |
ACO Participant Representative |
Community Hospital Group, Inc |
Hand |
Richard |
CFO |
0 |
Other |
|
McCoy |
Sheilah |
Director of Care Coordination |
0 |
Other |
|
Key ACO Clinical and Administrative Leadership:
William Oser | ACO Executive |
Robin Winter | Medical Director |
Thomas Flynn | Compliance Officer |
Dr. Robert Bayly | Quality Assurance/Improvement Officer |
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name and Position |
ACO Quality Committee | Dr. Bhudev Sharma, MD Chairman |
ACO Finance Committee | Mr. Richard Hand, CFO Chairman |
Types of ACO participants, or combinations of participants, that formed the ACO:
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2020, $2,377,082.09
- Performance Year 2020, $2,377,082.09
- Second Agreement Period
- Performance Year 2019, $3,661,811.05
- Performance Year 2018, $4,233,662.16
- Performance Year 2017, $0
- First Agreement Period
- Performance Year 2016, $0
- Performance Year 2015, $0
- Performance Year 2014, $0
Shared Savings Distribution
- Third Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 50%
- Proportion invested in redesigned care processes/resources: 0
- Proportion of distribution to ACO participants: 50%
- Performance Year 2020
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 50%
- Proportion invested in redesigned care processes/resources: 0
- Proportion of distribution to ACO participants: 50%
- Performance Year 2018
- Proportion invested in infrastructure: 26%
- Proportion invested in redesigned care processes/resources: 0
- Proportion of distribution to ACO participants:
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- First Agreement Period
- Performance Year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2014
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Quality Performance Results
Measure Number | Measure Name | Your ACO Performance Rate* | Current Year Mean Performance Rate (SSP ACOs) |
ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | 0.90 | 0.95 |
ACO-13 | Falls: Screening for Future Fall Risk | 74.86 | 84.97 |
ACO-14 | Preventive Care and Screening: Influenza Immunization | 71.49 | 76.03 |
ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 93.33 | 81.67 |
ACO-18 | Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan | 44.61 | 71.46 |
ACO-19 | Colorectal Cancer Screening | 62.28 | 72.59 |
ACO-20 | Breast Cancer Screening | 62.56 | 74.05 |
ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 89.49 | 83.37 |
ACO-27 | Diabetes Mellitus: Hemoglobin A1c Poor Control | 12.68 | 14.70 |
ACO-28 | Hypertension (HTN): Controlling High Blood Pressure | 80.68 | 72.87 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
Note: For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.